Month: April 2023

Polivy combination is the first FDA-approved therapy in nearly 20 years for the first-line treatment of diffuse large B-cell lymphoma, an aggressive disease and the most common form of non-Hodgkin lymphoma in the US POLARIX trial showed the Polivy combination reduced the risk of disease progression, relapse or death by 27% compared to the standard of care, R-CHOP, with a comparable safety profile First-line treatment with Polivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progressionBasel, 19 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP) for the treatment...

Company announcement – No. 15 / 2023 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 Copenhagen, Denmark, April 19, 2023 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the implementation of a long-term incentive program (the “LTIP”) for Zealand’s Board of Directors, Corporate Management and employees in accordance with Zealand’s remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on March 29, 2023 (“Remuneration Policy”). Long-term incentive program Zealand has awarded 40,500 restricted stock units (“RSUs”) to Zealand’s...

Paris, 19 April 2023 Air France-KLM and Air France announce today the full exit of the French Recapitalization State Aid under the EU Covid–19 Temporary FrameworkAir France-KLM has fully repaid, the €300 million remaining French State hybrid perpetual bonds and paid the required compensation of the French State for the shares subscribed in April 2021 without change required of the capital ownership The Group has therefore refinanced €407 million with a new issuance of hybrid perpetual bonds with the French State, without any restrictions attached.Following the intention expressed during the presentation of the Group’s Full Year 2022 results on February 17, 2023, Air France-KLM today announces the final repayment of the outstanding perpetual hybrid bonds held by the French State, as well as the required compensation of the French...

New contract will support NASA’s Artemis Missions VI-VIII REDMOND, Wash., April 19, 2023 (GLOBE NEWSWIRE) — Aerojet Rocketdyne recently received a $67 million contract award from Lockheed Martin to provide propulsion systems for the Orion spacecraft that are planned to launch on Artemis missions VI-VIII. This new work is an extension of the 2019 Orion Production and Operations Contract (OPOC). The Orion spacecraft recently completed a successful test flight during NASA’s Artemis I mission, proving it is capable of safely carrying humans to deep space on Artemis II. “Aerojet Rocketdyne propulsion on NASA’s Orion spacecraft and Space Launch System rocket contributed to the success of the historic Artemis I mission, from liftoff to splashdown,” said Aerojet Rocketdyne CEO and President Eileen P. Drake. “We’re proud to be part of a...

Jupiter, FL, April 19, 2023 (GLOBE NEWSWIRE) — Jupiter Wellness Acquisition Corp. (Nasdaq: JWAC) (“JWAC”) announced today that its special meeting of stockholders (the “Meeting”), which was originally scheduled for April 20, 2023, has been postponed to 10:00 a.m. Eastern Time, on Tuesday, May 2, 2023. At the Meeting, stockholders of JWAC will be asked to vote on proposals to approve, among other things, its initial business combination with Chijet Inc., a Cayman Islands exempted company (“Chijet”), each of the referenced holders of Chijet’s outstanding shares (collectively, the “Sellers”), Chijet Motor Company, Inc., a Cayman Islands exempted company and wholly-owned subsidiary of Chijet (“Pubco”), and Chijet Motor (USA) Company, Inc., a Delaware corporation and a wholly-owned subsidiary of Pubco (“Merger Sub”), which JWAC previously...